...

• September 3-October 1: Application system open  

• October 4: COE Faculty Affairs completes applicant eligibility review  

• October 9-November 8: COE committee review of FDA applications  

• November 9: Deadline for COE review committee to forward recommendations to Dean 

• November 10-17: Dean review  

• November 18: Dean sends FDA awardee recommendations to EVPP 

• December 18: EVPP notifies awardees  

• February 17: FDA recipients’ acceptance forms due to COE Faculty Affairs 

Eligibility

2024-25 guidelines will be posted August 1, 2024.

Faculty are encouraged to confirm their eligibility prior to applying. Eligibility will be confirmed by the COE Assistant Director for Faculty Affairs and the Provost’s Office prior to review. 

...

• Current professional-track position in any rank in the instruction, practice, clinical, research or lecturer title series. 

• At the time of application, has served in a professional-track position of at least 50% FTE in both the fall and spring terms during each of the two consecutive academic years immediately preceding the academic year of FDA their application (i.e., in both 2022-23 and 2023-24). 

  • For information about specific scenarios, see UT FDA Guidelines 2024-25 FINAL.docx > Section B. Timing.

• Has met or exceeded expectations on their annual reviews in their two most recent years of benefits-eligible service preceding this FDA application (i.e. 2022-23 and 2023-24).

  • If applicant did not receive annual reviews in their two most recent years of benefits-eligible service, the department chair/immediate supervisor must contact EVPP Faculty Affairs to request an exception, and the exception must be approved.

• Any previous FDA awarded ended no later than summer 2023.

• Department chair and/or immediate supervisor approve the proposed timing of activities in their FDA application. 

• Proposed FDA budget totals no more than $10,000 and includes only allowable items that support research and professional development activities as outlined in Section A.3 of UT FDA Guidelines 2024-25 FINAL.docx.

• All requirements described at the following:

  • "Eligibility" section of EVPP: Faculty Development Award

  • UT FDA Guidelines 2024-25.pdf

  • 2024-25 COE guidelines at EVPP: Faculty Development Award > "College and School FDL Guidelines" in right-hand side bar > "College of Education" 

...